Global Enteral Nutrition Market - Focused Insights 2025-2030

The global enteral nutrition market is expected to grow at a CAGR of 6.78% from 2024 to 2030.

ENTERAL NUTRITION MARKET NEWS

• In March 2025, Nutrisens Group, one of the emerging companies in clinical nutrition, aims to expand its presence in Latin America with the acquisition of Brazilian Prediet Medical Nutrition, which manufactures oral and enteral nutrition products in a range of forms, including powder, liquid, and tube feeding. This acquisition will strengthen Nutrisens' portfolio as well as regional market penetration.
• In 2024, Danone, one of the leading market players in the enteral nutrition market, acquired Functional Formularies, a leading whole food tube feeding business in the US. This acquisition is strengthening Danone's Medical Nutrition portfolio by further expanding its tube feeding (enteral nutrition) portfolio.
• Also, in 2024, Danone acquired Kate Farms to enhance its whole tube feeding (enteral nutrition) formulas. Kate Farms is a tube feeding formula developing company that is strengthening Danone's enteral nutrition portfolio with natural ingredient-based tube-feeding products that are globally recognized.

KEY TAKEAWAYS

• By Feeding Method: In 2024, the tube feeding segment accounted for the largest market share of over 57%.
• By Patient Group: The adult segment shows the highest growth of 6.97% during the forecast period.
• By Indication: The oncology segment dominates and holds the largest market share in 2024.
• By End-User: The hospital segment accounted for the largest share of the global enteral nutrition market.
• By Geography: APAC is the most dominant region for the enteral nutrition market, accounting for around 41% of the share in the global market.
• Growth Factor: The global enteral nutrition market is set to grow due to a significant rise in the patient pool of cancer and neurological diseases and a paradigm shift from parenteral to enteral nutrition.

ENTERAL NUTRITION MARKET TRENDS & DRIVERS

Paradigm Shift From Parenteral to Enteral Nutrition

Over the past few years, there has been a paradigm shift towards enteral nutrition with tube feeding compared to parenteral nutrition. For instance, tube feeding is considered a primary artificial nutrition choice in patients compared to parenteral nutrition if the GI tract is functioning properly. There is a consensus among clinicians that enteral feeding should be the preferred route for nutritional support if patients have a functioning and accessible GI tract. Furthermore, the National Library of Medicine report 2023 revealed that medical professionals as well as patients prefer enteral nutrition over parenteral due to its affordability and associated complications and risks, such as blood clots and infection development.

Technology and Formulation Advancements in Enteral Nutrition

Enteral nutrition is commonly administered by oral or tube feeding methods. Among these two methods, tube feeding methods are effective but challenging. These factors led to continued developments in tube feeding methods. Advanced materials used in enteral tube manufacturing, new technologies, and new designs enhance the tube feeding effectiveness for enter nutrition. One of the most recent advancements in enteral nutrition tube feeding is the use of closed systems. This new system enables the administration of nutrition without exposing the feeding tube or the patient to outside contaminants (foreign bodies), thereby reducing the risk of infection and several other complications. Furthermore, one new development is the development of unique formulations that can target specific conditions and become a popular choice among health professionals. This factor increases customization in EN therapies and is expected to deliver lucrative revenue growth opportunities.

Malnutrition - a Global Health Concern

Malnutrition is a global concern and is on the rise even after several government programs and initiatives. Malnutrition is a condition that is primarily associated with poverty and medical conditions. Malnutrition, in all its forms, includes overweight, obesity, undernutrition (wasting, stunting, and underweight), and resulting diet-related noncommunicable diseases. The World Health Organization (WHO) reported that in 2024, more than 2.5 billion individuals will be affected by any one form of malnutrition.

Significant Rise in Patient Pool of Cancer and Neurological Diseases

Cancer and Neurological diseases are the two most common health conditions that lead to an increased prevalence of malnutrition as well as a rise in dysphagia among patients. Globally, these two health conditions have become major public health concerns. According to the WHO, globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths. The cancer burden will increase by approximately 75% over the next two decades. The predicted global burden will increase to about 35 million new cases by 2050, with the greatest increase occurring in low- and middle-income countries. This high prevalence of various cancers across the world will drive enteral nutrition among cancer patients, which will contribute overall enteral feeding devices market.

ENTERAL NUTRITION MARKET SEGMENTATION INSIGHTS

INSIGHTS BY FEEDING METHOD

The global enteral nutrition market by feeding method is segmented into tube feeding and oral feeding. In 2024, the tube-feeding segment accounted for the largest market share of over 57%. This method involves delivering nutrition directly into the gastrointestinal tract through a tube that is inserted via the mouth, nose, or stomach. Tube feeding is the most commonly used method when a patient is unable to swallow meals or clinical nutrition products due to a dysphagia condition. Also, when a patient/person is unable to meet their daily nutrition requirement through oral clinical nutrition products receive enteral nutrition deliveries. When a patient has a condition that prevents food from traveling the traditional route through the GI tract from the mouth to the esophagus and from the esophagus to the stomach to the small intestine, the tube feeding method is widely considered. The Health Nutrition Council report 2023 revealed that the tube feeding method is the most used method that has proven to adequately support providing life-sustaining nutrients, and it is often required as the first option feeding method when oral enteral nutrition delivery is impossible.

It reduces the chances of failure of nutritional therapies, increases effectiveness, and offers rapid recovery from malnutrition. Adults as well as the pediatric population received EN through tube feeding methods. The growing number of chronic diseases in adults and associated dysphagia conditions, as well as rising infant births with low birth weight, are accelerating the demand for tube-feeding EN deliveries.

INSIGHTS BY PATIENT GROUP

By patient group, the adult segment shows the highest growth of 6.97% during the forecast period. In the adult segment, aging individuals and the geriatric population significantly contribute to the demand for enteral nutrition (EN) therapies due to the prevalence of chronic diseases and associated swallowing difficulties. The adult population (aged 18 and above) is severely affected by chronic conditions such as diabetes, cardiovascular diseases (CVD), cancer, neurological disorders, and gastrointestinal diseases, which often necessitate enteral nutrition support. According to the World Health Organization (WHO), more than 390 million adults globally are undernourished and require nutritional therapies due to the severe impact of these conditions on their health. Adults represent one of the largest patient groups in need of EN therapies.

Among adults, cancer, cardiovascular diseases (CVD), diabetes, heart disease, and stroke remain some of the leading causes of death worldwide. Additionally, the Diabetes Atlas 2025 highlights a significant global burden of diabetes among adults. WHO data also indicates a widespread prevalence of cancer and neurological disorders across the adult population globally.

INSIGHTS BY INDICATION

Based on the indication, the oncology segment dominates and holds the largest global enteral nutrition market share in 2024. Globally, the rising incidence of cancer is leading to an increased prevalence of associated malnutrition. According to the Nutrition Journal (2024), a significant proportion of cancer patients are at high risk of severe malnutrition. The Oncotarget Journal (2022) reported that hospital studies in Europe revealed that one in three cancer patients are at risk of malnutrition and often receive nutritional support therapies. Furthermore, the WHO's 2024 report on the global cancer burden highlighted a substantial increase in the number of cancer cases, projecting a dramatic rise by 2050. Malnutrition is common among cancer patients due to the disease itself, complications such as tumors, and the effects of medical and anticancer treatments. A significant portion of cancer-related mortality is attributed to the severe impacts of malnutrition, where enteral nutrition plays a crucial role in comprehensive cancer care. Among all health conditions, the use of enteral nutrition is relatively higher in cancer patients. The growing prevalence of various cancers-particularly gastric, head and neck/throat, and esophageal cancers-combined with the rising need for nutritional support, is significantly contributing to the growth of the enteral nutrition market.

INSIGHTS BY END-USER

The global enteral nutrition market by end-users is categorized into hospitals, outpatient care settings, and home care settings. Hospitals are the primary contributors to growth in the enteral nutrition (EN) market. The rising prevalence of chronic diseases and the corresponding increase in hospital admissions have significantly driven the demand for EN therapies in hospital settings. Moreover, the growing number of hospitals, along with the expansion of critical care units and intensive care units (ICUs), further contributes to the rising demand for enteral nutrition. ICU admissions often exacerbate the risk of malnutrition, increasing the need for nutritional support through enteral solutions. The incidence of malnutrition among hospitalized patients has grown, fueling the adoption of EN therapies.

Additionally, the presence of skilled healthcare professionals with expertise in enteral nutrition makes hospitals a preferred choice over other healthcare settings for patients requiring long-term care. Globally, a substantial proportion of patients with severe chronic conditions are hospitalized for extended periods. For example, in the U.S., gastrointestinal (GI) diseases account for millions of hospital admissions annually. The growing burden of GI disorders has led to a steady rise in enteral feeding procedures, thereby boosting the growth of the hospital segment in the enteral nutrition market.

ENTERAL NUTRITION MARKET GEOGRAPHICAL ANALYSIS

APAC is the most dominant region for the global enteral nutrition market, accounting for around 41% of the share. In the APAC region, the demand for enteral nutrition (EN) therapies is driven by a large and diverse target patient population. This includes the growing geriatric population with chronic diseases, pediatric patients with low birth weight or malnutrition, and critically ill individuals suffering from accidental or physical injuries-all of whom contribute significantly to the rising need for EN therapies.

China and India are among the leading countries in APAC with a substantial target patient base. Meanwhile, Japan also shows considerable demand for enteral nutrition due to broad healthcare access and higher spending on related services and solutions.

Home enteral nutrition (HEN) delivery is gaining popularity in several APAC countries. Australia has demonstrated strong support through healthcare infrastructure and funding for HEN services. In Japan, the National Health Insurance program offers comprehensive coverage for home-based EN services. In India, both public and private health insurance policies cover portions of HEN services and products. These supportive factors are contributing to the increasing demand for enteral nutrition in home care settings across the region.

ENTERAL NUTRITION MARKET VENDOR LANDSCAPE

The global enteral nutrition market report contains exclusive data on 16 vendors. The market is characterized by high market concentration and high competition among players. The present scenario is driving vendors to alter and refine their unique value propositions to achieve a strong market presence. The market is prone to the threat of infiltration with low-quality products. The major vendors in the market continually compete for the leading position, with occasional spurts of competition from other local vendors. The market is characterized by the presence of diversified global and regional vendors. As international players expand their market footprint, regional vendors are estimated to find it increasingly difficult to compete with these global players.

The future of the global enteral nutrition market will rely on new products launched with advancements such as unique formulations, higher effectiveness, and easy tolerance. Furthermore, strategic mergers and acquisitions, collaboration, and partnerships positively influence the competition among vendors.

Key Vendors

• Abbott
• B. Braun SE
• Danone
• Nestle
• Fresenius Kabi AG

Other Prominent Vendors

• Ajinimoto Cambrooke
• Global Health Products
• Medtrition
• Medica Nutrition
• Megalabs USA, LLC. -Victus
• Meiji Holdings Co., Ltd.
• Nutrisens
• Otsuka Holdings
• Reckitt Benckiser Group PLC
• Solace Nutrition
• Whole Enteral

SEGMENTATION & FORECAST

• By Feeding Method
  • Tube Feeding
  • Oral Feeding
• By Patient Group
  • Adults
  • Pediatrics
• By Indication
  • Oncology
  • Gastrointestinal Disease (GI)
  • Neurological Diseases
  • Cardiology & Pulmonology Diseases
  • Other Indications
• By End-User
  • Hospitals
  • Outpatient Care Settings
  • Homecare Settings
• By Geography
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

KEY QUESTIONS ANSWERED:

1. How big is the global enteral nutrition market?

2. What is the growth rate of the global enteral nutrition market?

3. Which type of enteral nutrition product will dominate the market growth?

4. What are the factors driving the global enteral nutrition market growth?

5. Which region dominates the global enteral nutrition market growth?

6. Who are the major players in the global enteral nutrition market?